Source:http://linkedlifedata.com/resource/umls/id/C1513403
NCI: Every point of difference between premalignant or malignant cells and their normal counterparts is a potential target of opportunity for drug discovery - a molecular target of prevention or treatment. (Bypass Budget, 2002)